US

Pavan Bhat


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Pavan Bhat: Innovator in Pharmaceutical Formulations

Introduction

Pavan Bhat is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of extended release dosage forms. His innovative work has the potential to enhance the efficacy of medications and improve patient outcomes.

Latest Patents

Pavan Bhat has developed several notable patents, including an "Extended Release Formulation Containing A Wax." This patent discloses pharmaceutical formulations that feature both an extended release portion and an immediate release portion, with the extended release portion comprising an active pharmaceutical ingredient and a wax. Another significant patent is the "Extended-Release Dosage Form," which provides pharmaceutical formulations that include sustained release particles. These particles consist of an inner core bead containing an active pharmaceutical ingredient, an intermediate coating, and an outer coating made of a pH-independent polymer. This innovation also includes methods for preparing extended release dosage compositions with varying drug release profiles.

Career Highlights

Throughout his career, Pavan Bhat has worked with prominent companies in the pharmaceutical industry, including Mylan Technologies, Inc. and Mylan Pharmaceuticals Inc. His experience in these organizations has allowed him to refine his expertise in drug formulation and development.

Collaborations

Pavan has collaborated with several professionals in the field, including Kristin Jackson and Kenneth J. Miller. These collaborations have contributed to the advancement of his research and the successful development of his patented formulations.

Conclusion

Pavan Bhat is a notable inventor whose work in pharmaceutical formulations has the potential to significantly impact the industry. His innovative patents and collaborations reflect his commitment to improving drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…